Your search returned 8 results.

Results
	1.	Phase I trial of a new schedule of romidepsin in patients with advanced cancers. MedStar authors: Ghafourian, Kambiz PMID: 23757352 Citation: Clinical Cancer Research. 19(16):4499-507, 2013 Aug 15. Institution: MedStar Washington Hospital Center Department: Medicine/General Internal Medicine Medline publication type: Clinical Trial, Phase I Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amiri-Kordestani L, Bates SE, Draper D, Figg WD, Fojo T, Frye R, Ghafourian K, Luchenko V, Peer CJ, Piekarz RL, Reynolds J, Skarulis M, Venzon D, Woo S, Wright J DOI: http://dx.doi.org/10.1158/1078-0432.CCR-13-0095 Add to cart (remove)
	2.	Approach to the surgical management of resectable gastric cancer. [Review] MedStar authors: Al-Refaie, Waddah B PMID: 27166607 Year: 2016 Citation: Clinical Advances in Hematology & Oncology. 14(4):249-57, 2016 Apr Institution: MedStar Health Research Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Al-Refaie WB, Hong YK, Quadri HS Add to cart (remove)
	3.	Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer. MedStar authors: Al-Refaie, Waddah B PMID: 27865602 Year: 2017 Citation: Surgery. 161(4):968-976, 2017 Apr Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Al-Refaie W, Ayata G, de Geus SW, Eskander MF, Kasumova GG, Ng SC, Tseng JF DOI: https://dx.doi.org/10.1016/j.surg.2016.09.032 Add to cart (remove)
	4.	Results of cement versus bone graft reconstruction after intralesional curettage of bone tumors in the skeletally immature patient. MedStar authors: Henshaw, Robert M PMID: 23812148 Citation: Journal of Pediatric Orthopedics. 34(1):92-100, 2014 Jan. Institution: MedStar Washington Hospital Center Department: Orthopedic Oncology Medline publication type: Comparative Study Evaluation Studies Journal Article Form of publication: Journal Article All authors: Henshaw RM, Wallace MT DOI: http://dx.doi.org/10.1097/BPO.0b013e31829b2f61 Add to cart (remove)
	5.	Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors: Kumar, Anjali S PMID: 26187751 Citation: Lancet Oncology. 16(8):957-66, 2015 Aug. Institution: MedStar Washington Hospital Center Department: Surgery/Colorectal Surgery Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG DOI: http://dx.doi.org/10.1016/S1470-2045(15)00004-2 Add to cart (remove)
	6.	Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors: Priebat, Dennis A PMID: 28988646 Year: 2017 Citation: Lancet Oncology. 18(11):1493-1501, 2017 Nov Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II DOI: https://dx.doi.org/10.1016/S1470-2045(17)30624-1 Add to cart (remove)
	7.	Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors: Asch, Federico M Barac, Ana Cunningham, A Gallagher, Christopher Hofmeyer, Mark Srichai, M B Swain, Sandra M PMID: 30852761 Year: 2019 Citation: Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun. Institution: MedStar Health MedStar Health Research Institute MedStar Heart & Vascular Institute Washington Cancer Institute Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF DOI: https://dx.doi.org/10.1007/s10549-019-05191-2 Add to cart (remove)
	8.	Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. MedStar authors: Rao, Suman PMID: 29129441 Year: 2017 Citation: Lancet Oncology. 18(12):1600-1609, 2017 Dec Institution: MedStar Franklin Square Hospital Medline publication type: Journal Article Form of publication: Journal Article All authors: Brahmer JR, Csoszi T, Cuffe S, Deitz AC, Fulop A, Gottfried M, Hotta K, Hui R, Lubiniecki GM, O'Brien M, Peled N, Rangwala R, Rao S, Reck M, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhang J DOI: https://dx.doi.org/10.1016/S1470-2045(17)30690-3 Add to cart (remove)

Powered by Koha